Apogee Therapeutics, Inc. Common Stock (APGE)

Apogee Therapeutics, Inc. Common Stock (APGE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Sep 3, 2026: market cap $10.2B; returns 1 week +0.1%, 1 year +254.0%.

Apogee Therapeutics is a clinical-stage biotechnology company focused on developing novel biologic therapies for a wide range of inflammatory and immunology (I&I) diseases. As a clinical-stage entity, the company does not currently generate revenue from product sales.

APGE financial model: income statement, cash flow and balance sheet